Testing evidence43 / 50
429 accepted testing records were counted. Held and rejected records stayed out.
Standard grade
Testing, transparency, and catalog integrity data were observed and scored on the current 100-point rubric. Public discussion is not included in the score.
Grade and evidence review: Sep 12, 2026.
How the grade was built · Sep 12, 2026
429 accepted testing records were counted. Held and rejected records stayed out.
6 public identity, policy, catalog, or testing pages were successfully checked.
Listing resolution, exact-basis coverage, freshness, and testing traceability contributed 30 points in the Sep 12, 2026 review.
Public discussion is context only and does not affect this score. Catalog integrity supplies the 30-point third component. Price updates do not change this dated grade.
Open the detailed evidence summary →Catalog and recorded prices
Catalog listings reflect the Sep 12, 2026 review. Price and stock observations can change; compare the exact product and confirm availability with the vendor.
| Compound | Catalog listings | Recorded offers | In stock when observed | Lowest effective price | That price observed | Compare |
|---|---|---|---|---|---|---|
| AHK-Cu | 1 | 0 | Not recorded | Not available | Not available | View record → |
| AOD-9604 | 1 | 1 | 1 | $402 mg vial | Sep 21, 2026 | Compare this product → |
| BPC-157 | 2 | 2 | 2 | $355 mg vial | Sep 21, 2026 | Compare this product → |
| Cagrilintide | 2 | 2 | 2 | $805 mg vial | Sep 21, 2026 | Compare this product → |
| CJC-1295 | 1 | 1 | 1 | $6010 mg vial | Sep 21, 2026 | Compare this product → |
| CJC-1295/Ipamorelin Blend | 1 | 1 | 1 | $6010 mg vial | Sep 21, 2026 | Compare this product → |
| DSIP | 1 | 1 | 1 | $405 mg vial | Sep 21, 2026 | Compare this product → |
| Epithalon | 2 | 2 | 2 | $3510 mg vial | Sep 21, 2026 | Compare this product → |
| FOXO4-DRI | 1 | 1 | 0 | $25010 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| GHK (basic, copper-free) | 1 | 1 | 1 | $4050 mg vial | Sep 21, 2026 | Compare this product → |
| GHK-Cu | 2 | 1 | 1 | $3550 mg vial | Sep 21, 2026 | Compare this product → |
| GLOW Blend (GHK-Cu/BPC-157/TB-500) | 2 | 2 | 2 | $8950 mg vial | Sep 21, 2026 | Compare this product → |
| Glutathione | 1 | 1 | 0 | $60600 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| IGF-1 LR3 | 1 | 1 | 1 | $851 mg vial | Sep 21, 2026 | Compare this product → |
| Ipamorelin | 1 | 1 | 1 | $5010 mg vial | Sep 21, 2026 | Compare this product → |
| KLOW Blend (GHK-Cu/BPC-157/TB-500/KPV) | 1 | 1 | 1 | $12580 mg vial | Sep 21, 2026 | Compare this product → |
| KPV | 1 | 1 | 1 | $5510 mg vial | Sep 21, 2026 | Compare this product → |
| LL-37 | 1 | 1 | 1 | $12510 mg vial | Sep 21, 2026 | Compare this product → |
| Mazdutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Melanotan I | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Melanotan II | 1 | 0 | Not recorded | Not available | Not available | View record → |
| MOTS-c | 1 | 1 | 1 | $5510 mg vial | Sep 21, 2026 | Compare this product → |
| NAD+ | 1 | 1 | 1 | $90500 mg vial | Sep 21, 2026 | Compare this product → |
| PE-22-28 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| PNC-27 | 1 | 1 | 0 | $15010 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| PT-141 (Bremelanotide) | 2 | 1 | 1 | $4010 mg vial | Sep 21, 2026 | Compare this product → |
| Retatrutide | 5 | 4 | 4 | $505 mg vial | Sep 21, 2026 | Compare this product → |
| Selank | 1 | 1 | 1 | $4010 mg vial | Sep 21, 2026 | Compare this product → |
| Semaglutide | 5 | 4 | 4 | $23.10Automatic quantity fixed amount off · listed $302 mg vial | Sep 21, 2026 | Compare this product → |
| Semaglutide/Cagrilintide Blend | 2 | 0 | Not recorded | Not available | Not available | View record → |
| Semax | 1 | 1 | 1 | $4010 mg vial | Sep 21, 2026 | Compare this product → |
| Sermorelin | 1 | 1 | 1 | $7510 mg vial | Sep 21, 2026 | Compare this product → |
| Setmelanotide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| SNAP-8 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| SS-31 (Elamipretide) | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Survodutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| TB-500 | 1 | 1 | 1 | $7010 mg vial | Sep 21, 2026 | Compare this product → |
| Tesamorelin | 1 | 1 | 1 | $6510 mg vial | Sep 21, 2026 | Compare this product → |
| Thymosin Alpha-1 | 1 | 1 | 1 | $6510 mg vial | Sep 21, 2026 | Compare this product → |
| Thymulin | 1 | 1 | 1 | $4010 mg vial | Sep 21, 2026 | Compare this product → |
| Tirzepatide | 5 | 4 | 4 | $555 mg vial | Sep 21, 2026 | Compare this product → |
| Wolverine Blend (BPC-157/TB-500) | 1 | 1 | 1 | $11020 mg vial | Sep 21, 2026 | Compare this product → |